Laman UtamaCHGCY • OTCMKTS
Chugai Pharmaceutical ADR
$22.26
7 Feb, 12:18:31 PG GMT-5 · USD · OTCMKTS · Penafian
Sekuriti tersenarai AS
Tutup sebelumnya
$21.81
Julat hari
$22.17 - $23.01
Julat tahun
$14.52 - $26.00
Permodalan pasaran
11.62T JPY
Bilangan Purata
187.12K
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(JPY)Dis 2024Perubahan T/T
Hasil
302.07B10.32%
Perbelanjaan pengendalian
84.37B40.21%
Pendapatan bersih
91.56B0.39%
Margin untung bersih
30.31-9.01%
Pendapatan bagi setiap syer
——
EBITDA
153.87B18.81%
Kadar cukai berkesan
27.05%—
Jumlah aset
Jumlah liabiliti
(JPY)Dis 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
996.34B34.83%
Jumlah aset
2.21T14.27%
Jumlah liabiliti
306.87B-0.03%
Jumlah ekuiti
1.90T—
Syer tertunggak
1.65B—
Harga kepada buku
0.02—
Pulangan pada aset
14.42%—
Pulangan pada modal
16.66%—
Perubahan bersih dalam tunai
(JPY)Dis 2024Perubahan T/T
Pendapatan bersih
91.56B0.39%
Tunai daripada operasi
152.39B22.69%
Tunai daripada pelaburan
-16.90B-399.49%
Tunai daripada pembiayaan
-2.03B11.70%
Perubahan bersih dalam tunai
136.24B7.00%
Aliran tunai bebas
172.21B46.70%
Perihal
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Diasaskan
10 Mac 1925
Pekerja
7,604
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama